157 related articles for article (PubMed ID: 6171038)
41. Imaging of soft tissue tumors with Tc(V)-99m dimercaptosuccinic acid. A new tumor-seeking agent.
Ohta H; Endo K; Fujita T; Nakajima T; Sakahara H; Torizuka K; Shimizu Y; Hata N; Masuda H; Horiuchi K
Clin Nucl Med; 1984 Oct; 9(10):568-73. PubMed ID: 6091971
[TBL] [Abstract][Full Text] [Related]
42. Soft-tissue tumors: diagnosis with Tc-99m (V) dimercaptosuccinic acid scintigraphy.
Kobayashi H; Sakahara H; Hosono M; Shirato M; Endo K; Kotoura Y; Yamamuro T; Konishi J
Radiology; 1994 Jan; 190(1):277-80. PubMed ID: 8259419
[TBL] [Abstract][Full Text] [Related]
43. The value of Tc-99m-tetrofosmin scintigraphy in the assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors.
Yapar Z; Kibar M; Yapar AF; Uguz A; Ozbarlas S; Gonlusen G
Ann Nucl Med; 2003 Sep; 17(6):443-9. PubMed ID: 14575377
[TBL] [Abstract][Full Text] [Related]
44. Is there a need for dedicated bone imaging in addition to 18F-FDG PET/CT imaging in pediatric sarcoma patients?
Walter F; Czernin J; Hall T; Allen-Auerbach M; Walter MA; Dunkelmann S; Federman N
J Pediatr Hematol Oncol; 2012 Mar; 34(2):131-6. PubMed ID: 22134608
[TBL] [Abstract][Full Text] [Related]
45. 99mTc-tetrofosmin scintigraphy in musculoskeletal tumours: the relationship between P-glycoprotein expression and tetrofosmin uptake in malignant lesions.
Yapar Z; Kibar M; Ozbarlas S; Yapar AF; Uguz A; Zorludemir S; Herdem M
Nucl Med Commun; 2002 Oct; 23(10):991-1000. PubMed ID: 12352598
[TBL] [Abstract][Full Text] [Related]
46. Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas.
Kostakoglu L; Panicek DM; Divgi CR; Botet J; Healy J; Larson SM; Abdel-Dayem HM
Eur J Nucl Med; 1996 Nov; 23(11):1558. PubMed ID: 9044869
[No Abstract] [Full Text] [Related]
47. Prediction of final tumor response to preoperative chemotherapy by Tc-99m MIBI imaging at the middle of chemotherapy in malignant bone and soft tissue tumors: comparison with Tl-201 imaging.
Taki J; Higuchi T; Sumiya H; Tsuchiya H; Minato H; Tomita K; Tonami N
J Orthop Res; 2008 Mar; 26(3):411-8. PubMed ID: 17960652
[TBL] [Abstract][Full Text] [Related]
48. Tl-201 and Tc-99m HMDP scintigraphic findings in extraskeletal osteosarcoma.
Kajihara M; Sugawara Y; Miki H; Mochizuki T; Kidani T; Sakayama K
Clin Nucl Med; 2005 May; 30(5):356-8. PubMed ID: 15827415
[TBL] [Abstract][Full Text] [Related]
49. Radiogallium accumulation in heterotopic bone.
Sziklas JJ; Vento JA; Spencer RP; Rosenberg RJ
Clin Nucl Med; 1985 May; 10(5):376. PubMed ID: 3160522
[No Abstract] [Full Text] [Related]
50. Imaging of primary Ewing sarcoma with 13N-L-glutamate.
Reiman RE; Rosen G; Gelbard AS; Benua RS; Laughlin JS
Radiology; 1982 Feb; 142(2):495-500. PubMed ID: 6119736
[TBL] [Abstract][Full Text] [Related]
51. A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases.
Pauwels EK; Blom J; Camps JA; Hermans J; Rijke AM
Eur J Nucl Med; 1983; 8(3):118-22. PubMed ID: 6220908
[TBL] [Abstract][Full Text] [Related]
52. Semiquantitative gallium scintigraphy in patients with osteogenic sarcoma.
Yeh SD; Rosen G; Caparros B; Benua RS
Clin Nucl Med; 1984 Apr; 9(4):175-83. PubMed ID: 6233055
[TBL] [Abstract][Full Text] [Related]
53. Comparative evaluation of 99mTc-pertechnetate, 99mTc-diphosphonate, 99mTc-Solcocitran, 99mTc-iron-ascorbic acid and 67Ga-citrate as brain scanning agents.
Pétursson E; Björnsson OG; Björnsson OJ; Davídsson D
Nuklearmedizin; 1982 Dec; 21(6):265-73. PubMed ID: 6300799
[TBL] [Abstract][Full Text] [Related]
54. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response.
Ramanna L; Waxman A; Binney G; Waxman S; Mirra J; Rosen G
J Nucl Med; 1990 May; 31(5):567-72. PubMed ID: 2341892
[TBL] [Abstract][Full Text] [Related]
55. Comparison of various rhenium-188-labeled diphosphonates for the treatment of bone metastases.
Hsieh BT; Hsieh JF; Tsai SC; Lin WY; Wang SJ; Ting G
Nucl Med Biol; 1999 Nov; 26(8):973-6. PubMed ID: 10708313
[TBL] [Abstract][Full Text] [Related]
56. [99mTc-pertechnetate scintigraphy in three cases with soft tissue tumors].
Oouchi Y; Iwamiya T; Suto Y; Ohta Y
Kaku Igaku; 1994 Jun; 31(6):609-12. PubMed ID: 8072235
[TBL] [Abstract][Full Text] [Related]
57. Role of skeletal scintigraphy in soft tissue sarcoma: Improving the diagnostic yield.
Barai S; Bandopadhayaya GP; Chumber S; Gupta DK; Patel CD; Dhanpati H
J Postgrad Med; 2004; 50(3):180-3; discussion 183-4. PubMed ID: 15377801
[TBL] [Abstract][Full Text] [Related]
58. [Evaluation of bone and soft tissue lesion using 99mTc-MIBI: comparison with 201Tl and the relation to chemotherapeutic effect].
Sumiya H; Taki J; Tonami N; Asada N; Tsuchiya H; Tomita K
Kaku Igaku; 1997 Feb; 34(2):105-11. PubMed ID: 9095573
[TBL] [Abstract][Full Text] [Related]
59. Tc-99m MDP and Ga-67 citrate accumulation in cutaneous metastases from colon carcinoma.
Palestro CJ; Coscia A; Richman AH
J Nucl Med; 1983 Dec; 24(12):1202-3. PubMed ID: 6227712
[No Abstract] [Full Text] [Related]
60. Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: concise communication.
Van Duzee BF; Schaefer JA; Ball JD; Chilton HM; Cowan RJ; Kuni C; Trow R; Watson NE
J Nucl Med; 1984 Feb; 25(2):166-9. PubMed ID: 6233404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
